Jennifer Masip will present the paper at the Conference on Retroviruses and Opportunistic Infections, which brings together more than 4000 leading researchers in HIV from almost 90 countries. Ms Masip is a member of the Infection and Immunity Research Group of the Joan XXIII University Hospital in Tarragona, the Pere Virgili Health Research Institute and the Universitat Rovira i Virgili.
Show all news from "Department of Medicine and Surgery"
The results of the study by a research team from the URV and the IISPV show a potential reduction of the current rate of reintubation from 9% to 1% by using machine learning tools. Data from a thousand intensive-care patients with respiratory difficulties has been processed and analysed to create this tool
This drug is currently taken by one in four people to reduce cholesterol in the blood and thus prevent cardiovascular diseases. URV-IISPV researcher Lluís Masana has coordinated a study carried out at 19 Catalan hospitals during the first wave of the pandemic
06/10/2020
The discoverers of the hepatitis C virus
The Nobel Prize has been awarded to Harvey J. Alter, Michael Houghton and Charles M. Rice, who have had a significant impact on improving global health. Thanks to their discovery, there are now highly sensitive blood tests that enable hepatitis C to be eliminated after a blood transfusion
Researchers from the NFOC-Salut group at the URV have analysed the results of the latest studies carried out in the frame of the AppleCOR project, which examines the effect of consuming anthocyanin-rich apple flesh on reducing cholesterol
Researchers have until 26 January 2018 to present their applications
Researchers at the URV and the Pere Virgili Health Research Institute (IISPV) have discovered why people with obesity not only accumulate glycogen in their muscles and liver, like other people, but also store it in their adipocytes, the cells that make up body fat. These fat cells stop working properly, causing the individual to develop insulin resistance and, potentially, type 2 diabetes. This is the first time that this metabolic pathway has been described and it makes glycogen a new player within the pathology of obesity